Religare Enterprises Board of Directors

Get the latest insights into the leadership at Religare Enterprises. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Rashmi Saluja Executive Chairperson
Mr. Hamid Ahmed Independent Director
Mr. Praveen Kumar Tripathi Independent Director
Mr. Malay Kumar Sinha Independent Director
Mr. Ranjan Dwivedi Independent Director
Mrs. Preeti Madan Independent Director

Religare Enterprises Share price

RELIGARE

237.5

0.50 (0.21%)
NSE
BSE
Last updated on 29 Aug, 2025 | 15:59 IST
BUYSELL
Today's High

240.65

Today's Low

235.65

52 Week Low

202.52

52 Week High

320.00

The current prices are delayed, login to your account for live prices

Religare Enterprises FAQs

The board at Religare Enterprises consists of experienced professionals, including Dr. Rashmi Saluja , Mr. Hamid Ahmed , and others, overseeing the company’s strategic and corporate governance.

Directors at Religare Enterprises are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Rashmi Saluja is the current chairman at Religare Enterprises.

Executive directors at Religare Enterprises are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Religare Enterprises adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Religare Enterprises, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.